Single Cell-Based Vector Tracing in Patients with ADA-SCID Treated with Stem Cell Gene Therapy

Clinical improvement in stem cell gene therapy (SCGT) for primary immunodeficiencies depends on the engraftment levels of genetically corrected cells, and tracing the transgene in each hematopoietic lineage is therefore extremely important in evaluating the efficacy of SCGT. We established a single...

Full description

Bibliographic Details
Main Authors: Yuka Igarashi, Toru Uchiyama, Tomoko Minegishi, Sirirat Takahashi, Nobuyuki Watanabe, Toshinao Kawai, Masafumi Yamada, Tadashi Ariga, Masafumi Onodera
Format: Article
Language:English
Published: Elsevier 2017-09-01
Series:Molecular Therapy: Methods & Clinical Development
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2329050117300700
_version_ 1811277534709415936
author Yuka Igarashi
Toru Uchiyama
Tomoko Minegishi
Sirirat Takahashi
Nobuyuki Watanabe
Toshinao Kawai
Masafumi Yamada
Tadashi Ariga
Masafumi Onodera
author_facet Yuka Igarashi
Toru Uchiyama
Tomoko Minegishi
Sirirat Takahashi
Nobuyuki Watanabe
Toshinao Kawai
Masafumi Yamada
Tadashi Ariga
Masafumi Onodera
author_sort Yuka Igarashi
collection DOAJ
description Clinical improvement in stem cell gene therapy (SCGT) for primary immunodeficiencies depends on the engraftment levels of genetically corrected cells, and tracing the transgene in each hematopoietic lineage is therefore extremely important in evaluating the efficacy of SCGT. We established a single cell-based droplet digital PCR (sc-ddPCR) method consisting of the encapsulation of a single cell into each droplet, followed by emulsion PCR with primers and probes specific for the transgene. A fluorescent signal in a droplet indicates the presence of a single cell carrying the target gene in its genome, and this system can clearly determine the ratio of transgene-positive cells in the entire population at the genomic level. Using sc-ddPCR, we analyzed the engraftment of vector-transduced cells in two patients with severe combined immunodeficiency (SCID) who were treated with SCGT. Sufficient engraftment of the transduced cells was limited to the T cell lineage in peripheral blood (PB), and a small percentage of CD34+ cells exhibited vector integration in bone marrow, indicating that the transgene-positive cells in PB might have differentiated from a small population of stem cells or lineage-restricted precursor cells. sc-ddPCR is a simplified and powerful tool for the detailed assessment of transgene-positive cell distribution in patients treated with SCGT.
first_indexed 2024-04-13T00:18:26Z
format Article
id doaj.art-ed70ec7c4d1c4466aa7a2d0b95a82b56
institution Directory Open Access Journal
issn 2329-0501
language English
last_indexed 2024-04-13T00:18:26Z
publishDate 2017-09-01
publisher Elsevier
record_format Article
series Molecular Therapy: Methods & Clinical Development
spelling doaj.art-ed70ec7c4d1c4466aa7a2d0b95a82b562022-12-22T03:10:52ZengElsevierMolecular Therapy: Methods & Clinical Development2329-05012017-09-016C81610.1016/j.omtm.2017.05.005Single Cell-Based Vector Tracing in Patients with ADA-SCID Treated with Stem Cell Gene TherapyYuka Igarashi0Toru Uchiyama1Tomoko Minegishi2Sirirat Takahashi3Nobuyuki Watanabe4Toshinao Kawai5Masafumi Yamada6Tadashi Ariga7Masafumi Onodera8Department of Human Genetics, National Center for Child Health and Development, Tokyo 157-8535, JapanDepartment of Human Genetics, National Center for Child Health and Development, Tokyo 157-8535, JapanDepartment of Human Genetics, National Center for Child Health and Development, Tokyo 157-8535, JapanDepartment of Human Genetics, National Center for Child Health and Development, Tokyo 157-8535, JapanDepartment of Human Genetics, National Center for Child Health and Development, Tokyo 157-8535, JapanDepartment of Human Genetics, National Center for Child Health and Development, Tokyo 157-8535, JapanDepartment of Pediatrics, Hokkaido University Graduate School of Medicine, Hokkaido 060-8638, JapanDepartment of Pediatrics, Hokkaido University Graduate School of Medicine, Hokkaido 060-8638, JapanDepartment of Human Genetics, National Center for Child Health and Development, Tokyo 157-8535, JapanClinical improvement in stem cell gene therapy (SCGT) for primary immunodeficiencies depends on the engraftment levels of genetically corrected cells, and tracing the transgene in each hematopoietic lineage is therefore extremely important in evaluating the efficacy of SCGT. We established a single cell-based droplet digital PCR (sc-ddPCR) method consisting of the encapsulation of a single cell into each droplet, followed by emulsion PCR with primers and probes specific for the transgene. A fluorescent signal in a droplet indicates the presence of a single cell carrying the target gene in its genome, and this system can clearly determine the ratio of transgene-positive cells in the entire population at the genomic level. Using sc-ddPCR, we analyzed the engraftment of vector-transduced cells in two patients with severe combined immunodeficiency (SCID) who were treated with SCGT. Sufficient engraftment of the transduced cells was limited to the T cell lineage in peripheral blood (PB), and a small percentage of CD34+ cells exhibited vector integration in bone marrow, indicating that the transgene-positive cells in PB might have differentiated from a small population of stem cells or lineage-restricted precursor cells. sc-ddPCR is a simplified and powerful tool for the detailed assessment of transgene-positive cell distribution in patients treated with SCGT.http://www.sciencedirect.com/science/article/pii/S2329050117300700gene therapyvector integrationsingle celldigital droplet PCRADA-SCID
spellingShingle Yuka Igarashi
Toru Uchiyama
Tomoko Minegishi
Sirirat Takahashi
Nobuyuki Watanabe
Toshinao Kawai
Masafumi Yamada
Tadashi Ariga
Masafumi Onodera
Single Cell-Based Vector Tracing in Patients with ADA-SCID Treated with Stem Cell Gene Therapy
Molecular Therapy: Methods & Clinical Development
gene therapy
vector integration
single cell
digital droplet PCR
ADA-SCID
title Single Cell-Based Vector Tracing in Patients with ADA-SCID Treated with Stem Cell Gene Therapy
title_full Single Cell-Based Vector Tracing in Patients with ADA-SCID Treated with Stem Cell Gene Therapy
title_fullStr Single Cell-Based Vector Tracing in Patients with ADA-SCID Treated with Stem Cell Gene Therapy
title_full_unstemmed Single Cell-Based Vector Tracing in Patients with ADA-SCID Treated with Stem Cell Gene Therapy
title_short Single Cell-Based Vector Tracing in Patients with ADA-SCID Treated with Stem Cell Gene Therapy
title_sort single cell based vector tracing in patients with ada scid treated with stem cell gene therapy
topic gene therapy
vector integration
single cell
digital droplet PCR
ADA-SCID
url http://www.sciencedirect.com/science/article/pii/S2329050117300700
work_keys_str_mv AT yukaigarashi singlecellbasedvectortracinginpatientswithadascidtreatedwithstemcellgenetherapy
AT toruuchiyama singlecellbasedvectortracinginpatientswithadascidtreatedwithstemcellgenetherapy
AT tomokominegishi singlecellbasedvectortracinginpatientswithadascidtreatedwithstemcellgenetherapy
AT sirirattakahashi singlecellbasedvectortracinginpatientswithadascidtreatedwithstemcellgenetherapy
AT nobuyukiwatanabe singlecellbasedvectortracinginpatientswithadascidtreatedwithstemcellgenetherapy
AT toshinaokawai singlecellbasedvectortracinginpatientswithadascidtreatedwithstemcellgenetherapy
AT masafumiyamada singlecellbasedvectortracinginpatientswithadascidtreatedwithstemcellgenetherapy
AT tadashiariga singlecellbasedvectortracinginpatientswithadascidtreatedwithstemcellgenetherapy
AT masafumionodera singlecellbasedvectortracinginpatientswithadascidtreatedwithstemcellgenetherapy